-- RPG Life Sciences' (NSE:RPGLIFE, BOM:532983) profit plunged to 299 million Indian rupees in the fiscal fourth quarter from 1.17 billion rupees a year ago, according to a Wednesday filing to the Indian stock exchanges by the pharmaceuticals manufacturer.
The company's shares jumped over 11% in Thursday's trade.
Earnings per share during the quarter ended March 31 fell to 18.08 rupees from the year-ago figure of 70.96 rupees.
Revenue from operations in fiscal Q4 increased to 1.77 billion rupees from 1.43 billion rupees a year earlier.
The board of directors recommended a final dividend of 24 rupees per share for the fiscal year ended March 31.